Dronedarone in high-risk permanent atrial fibrillation

Connolly, Stuart J; Camm, A John; Halperin, Jonathan L; Joyner, Campbell; Alings, Marco; Amerena, John; Atar, Dan; Avezum, Álvaro; Blomström, Per; Borggrefe, Martin; Budaj, Andrzej; Chen, Shih-Ann; Ching, Chi Keong; Commerford, Patrick; Dans, Antonio; Davy, Jean-Marc; Delacrétaz, Etienne; Di Pasquale, Giuseppe; Diaz, Rafael; Dorian, Paul; ... (2011). Dronedarone in high-risk permanent atrial fibrillation. New England journal of medicine NEJM, 365(24), pp. 2268-76. Waltham, Mass.: Massachusetts Medical Society MMS 10.1056/NEJMoa1109867

[img]
Preview
Text
nejmoa1109867.pdf - Published Version
Available under License Publisher holds Copyright.

Download (614kB) | Preview

Dronedarone restores sinus rhythm and reduces hospitalization or death in intermittent atrial fibrillation. It also lowers heart rate and blood pressure and has antiadrenergic and potential ventricular antiarrhythmic effects. We hypothesized that dronedarone would reduce major vascular events in high-risk permanent atrial fibrillation.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Delacrétaz, Etienne

ISSN:

0028-4793

Publisher:

Massachusetts Medical Society MMS

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:22

Last Modified:

23 Oct 2019 16:43

Publisher DOI:

10.1056/NEJMoa1109867

PubMed ID:

22082198

Web of Science ID:

000298031800007

BORIS DOI:

10.7892/boris.7372

URI:

https://boris.unibe.ch/id/eprint/7372 (FactScience: 212591)

Actions (login required)

Edit item Edit item
Provide Feedback